- Open Access
Practical guidelines for B-cell receptor repertoire sequencing analysis
Genome Medicine volume 7, Article number: 121 (2015)
High-throughput sequencing of B-cell immunoglobulin repertoires is increasingly being applied to gain insights into the adaptive immune response in healthy individuals and in those with a wide range of diseases. Recent applications include the study of autoimmunity, infection, allergy, cancer and aging. As sequencing technologies continue to improve, these repertoire sequencing experiments are producing ever larger datasets, with tens- to hundreds-of-millions of sequences. These data require specialized bioinformatics pipelines to be analyzed effectively. Numerous methods and tools have been developed to handle different steps of the analysis, and integrated software suites have recently been made available. However, the field has yet to converge on a standard pipeline for data processing and analysis. Common file formats for data sharing are also lacking. Here we provide a set of practical guidelines for B-cell receptor repertoire sequencing analysis, starting from raw sequencing reads and proceeding through pre-processing, determination of population structure, and analysis of repertoire properties. These include methods for unique molecular identifiers and sequencing error correction, V(D)J assignment and detection of novel alleles, clonal assignment, lineage tree construction, somatic hypermutation modeling, selection analysis, and analysis of stereotyped or convergent responses. The guidelines presented here highlight the major steps involved in the analysis of B-cell repertoire sequencing data, along with recommendations on how to avoid common pitfalls.
B-cell receptor repertoire sequencing
Rapid improvements in high-throughput sequencing (HTS) technologies are revolutionizing our ability to carry out large-scale genetic profiling studies. Applications of HTS to genomes (DNA sequencing (DNA-seq)), transcriptomes (RNA sequencing (RNA-seq)) and epigenomes (chromatin immunoprecipitation sequencing (ChIP-seq)) are becoming standard components of immune profiling. Each new technique has required the development of specialized computational methods to analyze these complex datasets and produce biologically interpretable results. More recently, HTS has been applied to study the diversity of B cells , each of which expresses a practically unique B-cell immunoglobulin receptor (BCR). These BCR repertoire sequencing (Rep-seq) studies have important basic science and clinical relevance . In addition to probing the fundamental processes underlying the immune system in healthy individuals [3–6], Rep-seq has the potential to reveal the mechanisms underlying autoimmune diseases [7–13], allergy [14–16], cancer [17–19] and aging [20–23]. Rep-seq may also shed new light on antibody discovery [24–27]. Although Rep-seq produces important basic science and clinical insights , the computational analysis pipelines required to analyze these data have not yet been standardized, and generally remain inaccessible to non-specialists. Thus, it is timely to provide an introduction to the major steps involved in B-cell Rep-seq analysis.
There are approximately 1010–1011 B cells in a human adult . These cells are critical components of adaptive immunity, and directly bind to pathogens through BCRs expressed on the cell surface. Each B cell expresses a different BCR that allows it to recognize a particular set of molecular patterns. For example, some B cells will bind to epitopes expressed by influenza A viruses, and others to smallpox viruses. Individual B cells gain this specificity during their development in the bone marrow, where they undergo a somatic rearrangement process that combines multiple germline-encoded gene segments to produce the BCR (Fig. 1). The large number of possible V(D)J segments, combined with additional (junctional) diversity, lead to a theoretical diversity of >1014, which is further increased during adaptive immune responses, when activated B cells undergo a process of somatic hypermutation (SHM). Overall, the result is that each B cell expresses a practically unique receptor, whose sequence is the outcome of both germline and somatic diversity.
This review will focus on the analysis of B-cell Rep-seq data sets. Rep-seq studies involve large-scale sequencing of DNA libraries, which are prepared by amplifying the genomic DNA (gDNA) or mRNA coding for the BCR using PCR (Fig. 1). The development of HTS technologies and library preparation methods for Rep-seq is an area of active research, and has been reviewed elsewhere [1, 29]. While the experimental technologies and analysis methods are in a phase of rapid evolution, recent studies share common analysis tasks. Many of these steps also apply to the analysis of T-cell receptor sequencing data, and these should be standardized and automated in the future. The development of software toolkits, such as pRESTO/Change-O [30, 31], take a step in this direction by providing independent modules that can be easily integrated. For bioinformaticians and others used to dealing with different types of HTS experimental data (such as DNA-seq and RNA-seq data), approaching Rep-seq data requires a change of mindset. First, BCR sequences are not encoded directly in the genome. While parts of the BCR can be traced back to segments encoded in the germline (that is, the V, D and J segments), the set of segments used by each receptor is something that needs to be inferred, as it is coded in a highly repetitive region of the genome and currently cannot be sequenced directly. Furthermore, these segments can be significantly modified during the rearrangement process and through SHM, which leads to >5 % of bases being mutated in many B-cell subsets. Thus, there are no pre-existing full-length templates to align the sequencing reads.
This review aims to provide step-by-step guidance to fundamental aspects of B-cell Rep-seq analysis. The analysis is divided into three stages: pre-processing of sequencing data, inference of B-cell population structure, and detailed repertoire analysis (Fig. 2).
The goal of the pre-processing stage is to transform the raw reads that are produced by HTS into error-corrected BCR sequences. As discussed below, factors such as sequencing depth, read length, paired-end versus single-end reads, and inclusion of unique molecular identifiers (UMIs; sometimes referred to as UIDs) affect the analysis steps that need to be taken. Pipelines will need to be run many times to determine the proper parameters and data flow. Therefore, if the data are very large (several million reads per sample are common), it is advisable to sample a random subset (say 10,000 reads) and carry out the steps below to make sure quality is reasonable and the read conforms to the experimental design. Once the analysis steps are integrated, and the parameters are fixed, the pre-processing pipeline can be run on the full data set. It is useful to keep track of how many sequences pass each step successfully so that outliers can be detected. The outliers may reflect steps for which the parameters need further tuning or may indicate issues related to the experiments. We split the pre-processing stage into three steps: quality control and read annotation; UMIs; and assembly of paired-end reads.
Quality control and read annotation
The typical starting point for pre-processing is a set of FASTQ (or FASTA) files , and the tools used in this stage of the analysis often utilize this file format. Throughout processing, sequence-level annotations will be accumulated (for example, average quality, primers used, UMIs, and so on). These annotations can be stored in a database and linked to the reads within the FASTQ files through a lookup table. An alternative is to propagate the accumulated annotations within the read headers, thus maintaining all the data together in the FASTQ format . If samples are multiplexed, the sequencing facility will normally de-multiplex the data into one FASTQ file for each sample. If the data are paired-end, each sample will produce two FASTQ files (one for each read-end). If the data have not been de-multiplexed by the sequencing facility, the first step in the analysis is to identify the sample identification tags (often referred to as multiplex identifiers (MIDs) or sample identifiers (SIDs)) to determine which reads belong to which samples. These MID tags typically consist of a short number of base pairs (commonly 6–16) that are located near the end(s) of the amplicon. If multiple MIDs are designed to be in each sequence, these should be checked for consistency in order to reduce the probability of misclassification of reads due to PCR and sequencing errors .
Individual reads differ in quality, which is measured at the base level using Phred-like scores . Read quality metrics can be computed and visualized with software such as FastQC . It is important to remember that the quality estimates output by the sequencer do not account for errors introduced at the reverse transcription and PCR amplification steps. It is desirable to have a Phred-like score >30 for a long stretch at the beginning of each read. Quality will typically drop near the end of each read . If the library is designed to have a lot of overlap in the paired reads, then low-quality positions at the ends of the reads can be cut at this stage to allow better assembly of the paired reads. Some reads will have overall low quality, and sequences with low average quality (for example, less than a threshold of ~20) should be removed. A Phred-like score of 20 means 1 error per 100 base pairs (p = 10−Q/10), where p is the probability of an erroneous base call and Q is the Phred-like score associated with this base). The appropriate quality thresholds to employ are dataset dependent, and insight may be gained by plotting the distribution of quality scores as a function of position in the sequence. Although more stringent quality cutoffs will lower the number of sequences, it is crucial to keep quality high in Rep-seq data since BCR sequences can differ from one another by single nucleotides.
After handling low-quality reads and bases, reads can be analyzed to identify, annotate, and mask the primers used. The location of the primer sequences depends on the library preparation protocol. A typical setup includes a collection of V segment primers at the 5′ end and a set of J (or constant region) primers at the 3′ end of the amplicon (Fig. 2). In library preparation protocols in which 5′ rapid amplification of cDNA ends (5′ RACE) is used, there will not be a V segment primer [37, 38]. Primers are identified by scoring the alignment of each potential primer to the read and choosing the best match. In this step, it is crucial to know where on the read (and on which read of a pair) each primer is located. Even when primers are expected to be at a particular location in the read, they may be off by a few bases due to insertions and deletions (indels). If searching for primers within a range of locations, plotting a histogram of the identified locations is recommended to make sure this conforms to experimental design. Reads produced by sequencing may be in unknown orientations, depending on the experimental protocol. In this case, primers may appear in a forward or reverse orientation (and on either read for a paired-end setup). In cases where the primer is found in the reverse complement orientation, it is a good idea to reverse complement the sequence so that all reads are in the same orientation for the remaining analysis steps.
Primers are typically associated with some information, which should be used to annotate the reads. For example, each constant region primer may be associated with a specific isotype (immunoglobulin (Ig)M, IgG, and so on). The part of the sequence that matches the primer should then be cut or masked (bases changed to N). This is because the region bound by the primer may not accurately reflect the state of the mRNA/DNA molecule being amplified. For example, a primer designed to match a germline V segment sequence may bind to sequences with somatic mutations, thus leading to inaccuracy in mutation identification in downstream analysis. Reads for which primers cannot be identified (or do not appear in the expected locations) should be discarded. When dealing with paired-end data, annotations need to be kept in sync between the read pairs. If discarding one read of a pair, it may be necessary to also discard the other read of the pair (if later steps of the analysis depend on having both ends). Several tools for this step include PANDAseq , PEAR , pRESTO , and USEARCH  (for a broader list and comparison of features see ).
Unique molecular identifiers
UMIs are highly diverse nucleotide tags appended to the mRNA, usually at the reverse transcription step . UMIs are usually located at a specific position(s) in a read (for example, a 12 base pair (bp) UMI at one end of the read or split as two 6 bp identifiers at opposite ends of the amplicon). The length of the UMI depends on protocol, but is typically around 15 bases [12, 42, 43]. The random nature of the UMI enables each sequence to be associated with a single mRNA molecule. They are designed to reduce PCR amplification biases and sequencing error rates through the generation of consensus sequences from all amplicons with the same UMI.
UMI information is first identified in each read, and then it is removed from the read and the read is annotated with the UMI sequence. Next, it should be checked that the UMIs conform to the experimental protocol by plotting the distribution of bases at each position in the UMI and the distribution of reads per UMI to make sure that there are no unexpected biases. It is possible for an mRNA molecule to end up with multiple UMIs owing to the accumulation of PCR and sequencing errors in the UMI. Important factors here include UMI length (the longer it is, the higher the potential for errors, while shorter UMIs reduce diversity), and the number of PCR cycles (more cycles increase the potential for errors). Thus, sequences with “similar” UMIs should be clustered together. To get a sense of the extent to which UMI errors affect the analysis for particular data sets, “distance-to-nearest” plots  can be made for the UMI. If two peaks are observed, the first peak is interpreted as the distance between UMIs originating from the same molecule, while the second peak reflects the distance between UMIs that originated from distinct molecules. Clustering approaches can be used for recognizing UMIs that are expected to correspond to the same pre-amplified mRNA molecule (for example, single linkage hierarchical clustering). However, it is possible that each of these UMI clusters corresponds to multiple mRNA molecules. This may be due to incorrect merging, insufficient UMI diversity (that is, UMI sequences that are too short, or bad quality such as GC content biases), or bad luck . Thus, when merging multiple UMIs into a single cluster, checking that the rest of the sequence is also similar is recommended. The sequences within the cluster would be expected to differ only due to PCR and sequencing errors. A second clustering step should be carried out on UMI clusters with high diversity, to further partition the sequences based on the non-UMI part of the reads.
Once the reads are partitioned into clusters, each corresponding to a single mRNA molecule, the next step is to build a consensus sequence from each cluster of reads. The consensus sequence utilizes information from all reads in the cluster and thus improves the reliability of the base calls. This can take into account the per-base quality scores, which can be propagated to the consensus sequence. Maintaining the quality scores and the number of reads can help in filtering steps later in the analysis. Overall, each UMI cluster results in a single consensus sequence (or two in paired-end setups). Available tools for this step include MiGEC  and pRESTO .
Assembly of paired-end reads
The length of the PCR amplicons being sequenced in a Rep-seq experiment varies considerably because the BCR sequences use different V, D and/or J segments, which can vary in length. Nucleotide addition and deletion at the junction regions further alters the sequence length distribution. For examples of length distributions see . Also, sequence lengths depend on where the primers are located, and can differ for each primer (for example, isotype primers may be at different locations relative to the V(D)J sequence). In most cases, experiments using paired-end sequencing are designed so that the two reads are expected to overlap each other. The actual extent of overlap depends on the BCR sequence and read length. Assembly of the two reads into a single BCR sequence can be done de novo by scoring different possible overlaps and choosing the most significant. Discarding reads that fail to assemble may bias the data towards shorter BCR sequences, which will have a longer overlapping region. When the overlap region is expected to be in the V segment, it is also possible to determine the relative positions of the reads by aligning them to the same germline V segment. This is especially useful when not all read pairs are expected to overlap, and Ns can be added between the reads to indicate positions that have not been sequenced. Several tools can be used to assemble paired-end reads [30, 39, 40]. As quality control, it is a good idea to analyze the distribution of overlap lengths to identify outliers. Since each read of a pair may be associated with different annotations (for example, which primers were identified), it is critical to merge these annotations so that they are all associated with the single assembled read. Similar to the case described earlier in which reads with the same UMI were merged, the base quality in the overlap region can be recomputed and propagated. At this point, another quality filtering step can be undertaken. This could include removing sequences with a low average quality, removing sequences with too many low-quality individual bases, or masking low-quality positions with Ns. For efficiency of the next steps, it is also useful to identify sequences that are identical at the nucleotide level, referred to as “duplicate” sequences, and group them to create a set of “unique” sequences. Identifying duplicate sequences is non-trivial when degenerate nucleotide symbols are present, since there may be multiple possible groupings (consider AN, AT and NT) or the consensus may create a sequence that does not exist (consider AN and NT). When grouping duplicate sequences, it is important to propagate annotations, and keep track of how much support there is for each unique sequence in the underlying data. To improve quality, each unique mRNA should be supported by a minimum level of evidence. One approach is to require a minimum number for the raw reads that were used to construct the sequence (for example, two). A more stringent approach could also require a minimum number of independent mRNA molecules (for example, two UMIs). This could help to control for errors at the reverse transcription step , at the expense of sequences with low BCR expression.
V(D)J germline segment assignment
In order to identify somatic mutations, it is necessary to infer the germline (pre-mutation) state for each observed sequence. This involves identifying the V(D)J segments that were rearranged to generate the BCR and determining the boundaries between each segment. Most commonly this is done by applying an algorithm to choose among a set of potential germline segments from a database of known segment alleles. Since the observed BCR sequences may be mutated, the identification is valid only in a statistical sense. As such, multiple potential germline segment combinations may be equally likely. In these cases, many tools for V(D)J assignment report multiple possible segments for each BCR sequence. In practice, it is common to use one of the matching segments and ignore the rest. This has the potential to introduce artificial mutations at positions where the possible segments differ from each other. Genotyping and clonal grouping, which are described below, can help reduce the number of sequences that have multiple segment assignments. For sequences that continue to have multiple possible germline segments, the positions that differ among these germline segments should be ignored when identifying somatic mutations, for example, by masking the differing position(s) in the germline with Ns.
There have been many approaches developed for V(D)J assignment [47–52]. Important features that distinguish these tools include web-based versus stand-alone versions, allowing the use of an arbitrary germline segment database, computing time, the quality of D segment calls, allowing multiple D segments in a single rearrangement, allowing inverted or no D segments, and the availability of source code. This is an active field of research, with each tool having particular strengths and weaknesses depending on the evaluation criteria and assumptions about the underlying data. Methods continue to be developed, and contests have even been run to inspire the development of improved methods . In general, V and J assignments are much more reliable than D segment assignments, as the D regions in BCR sequences are typically much shorter and highly altered during the rearrangement process.
The performance of V(D)J assignment methods crucially depends on the set of germline V(D)J segments. If the segment allele used by a BCR does not appear in the database, then the polymorphic position(s) will be identified as somatic mutation(s). The most widely used database is IMGT , and requires significant evidence to include alleles, while other databases such as UNSWIg have been developed to include alleles with less stringent criteria . However, it is clear from recent studies that the number of alleles in the human population is much larger than the number covered by any of these databases [55–57]. Identification of germline segments for other species is an active area of study [58–61], and these too are likely to expand over time. Thus, an important step in the analysis is to try and identify novel alleles directly from the data being analyzed using tools such as TIgGER . Determining haplotypes  can further improve V(D)J assignment by restricting the allowed V–J pairings. Determining the genotype of an individual can significantly improve the V(D)J assignment quality. Genotypes can be inferred either by studying sequences with low mutation frequencies or from sorted naive cells [5, 57]. In the future, it may be possible to obtain the set of germline alleles for an individual directly from DNA sequencing of non-B cells. Currently this is not possible as the region of the genome encoding these segments is highly repetitive and aligning short reads to it is challenging. However, as read lengths increase and alignment algorithms are further developed this is expected to be feasible in the near or intermediate future.
Once the V(D)J germline segments have been assigned, indels in the BCR sequence can be identified within these segments. Several methods assume that any identified indels in the V/J segments are the result of sequencing error, and will “correct” them (for example, by introducing a gap for deletions or removing insertions). Indels can occur during affinity maturation , although the frequency of occurrence is not yet clear, and these can be lost with many computational pipelines.
Having determined the germline state, it is common to partition the sequences into functional and non-functional groups. Non-functional sequences are defined by characteristics including: having a frameshift between the V and J segments; containing a stop codon; or containing a mutation in one of the invariant positions. These non-functional sequences may represent real sequences that were non-productively rearranged or acquired the modification in the course of affinity maturation. However, many are likely the result of experimental errors, especially when the data are derived from sequencing platforms that are prone to introducing indels at high rates in photopolymer tracts. It is common to discard non-functional sequences from the analysis. If it is desired to analyze non-productively rearranged sequences, it is important to focus on the subset of non-functional sequences that are most likely to have been produced during the rearrangement process (for example, those having frameshifts in the junction areas separating the V–D and D–J segments identified as N-additions or P-additions ).
Clonal expansion and affinity maturation characterize the adaptive B-cell response. The goal of this stage is to infer the dynamic population structure that results from these processes. Available tools for inferring population structure include Change-O , IgTree , and MiXCR . In this section we split the population structure inference stage into two steps: clonal grouping and B-cell lineage trees.
Clonal grouping (sometimes referred to as clonotyping) involves clustering the set of BCR sequences into B-cell clones, which are defined as a group of cells that are descended from a common ancestor. Unlike the case for T cells, members of a B-cell clone do not carry identical V(D)J sequences, but differ because of SHM. Thus, defining clones based on BCR sequence data is a difficult problem [67, 68]. Methods from machine learning and statistics have been adapted to this problem. Clonal grouping is generally restricted to heavy chain sequences, as the diversity of light chains is not sufficient to distinguish clones with reasonable certainty. As newer experimental protocols allow the determination of paired heavy and light chains [69, 70], these can both be combined.
The most basic method for identifying clonal groups involves two steps. First, sequences that have the same V and J segment calls, and junctions of the same length, are grouped. Second, the sequences within each group are clustered according to a sequence-based distance measure. Most commonly, the distance measure is focused on the junction region, and is defined by nucleotide similarity. When calculating this “hamming distance”, it is important to account for degenerate symbols (for example, Ns). Although it is common to look for clonal variants only among sequences that have junction regions of the same length, it is possible that SHM can introduce indels during the affinity maturation process . Clonal groups should be defined using nucleotide sequences, and not amino acids, since the rearrangement process and SHM operate at the nucleotide level. Moreover, convergent evolution can produce independent clonal variants with similar amino acid sequences [71, 72]. Other distance measures have been proposed that take into account the intrinsic biases of SHM . The idea behind these methods is that sequences that differ at an SHM hotspot position are more similar than those that are separated by a coldspot mutation. Given a distance measure, clustering can be done with standard approaches, such as hierarchical clustering using single, average or complete linkage. Each of these methods require a distance cutoff. This is commonly determined through inspection of a “distance-to-nearest” plot . An alternative to the clustering approach is to construct a lineage tree (see below), and cut the tree to create sub-trees, each of which corresponds to a clonal group . Maximum likelihood approaches have also been used [63, 74]. So far, there have not been rigorous comparisons of these methods. Once the clonal groups have been determined, these can be used to improve the initial V(D)J allele assignments, as all the sequences in a clone arise from the same germline state . In principle, clustering sequences into clones can also be done before or in parallel with V(D)J assignments .
It is important to consider the set of sequences on which clonal grouping is carried out. For example, if cells are collected from multiple tissues or different sorted B-cell subsets, these can be merged together before analysis to identify clonal groups that span multiple compartments. Sometimes reference sequences are also available (for example, antigen-specific sequences from other samples of the same subject [15, 77] or from the literature ), and these may also be added to the set of sequences. As the clonal groups can change depending on the full set of data, it is important to be consistent in the choice of data being used for the analysis. Clonal grouping could also be impacted by experimental factors such as sampling and sequencing depth. Two members of a clone that differ significantly may only be recognized as such if intermediate members — that share mutations with both — are sequenced. By definition, clones cannot span different individuals. Thus, looking at the frequency of clones that are shared across individuals can provide a measure of specificity for the clonal grouping method. Although so-called “public” junction sequences have been observed, these tend to be rare (at least in heavy chains) .
B-cell lineage trees
B-cell lineage trees are constructed from the set of sequences comprising each clone to infer the ancestral relationships among individual cells. The most frequently applied methods are maximum parsimony and maximum likelihood, which were originally developed in evolutionary biology . Briefly, maximum parsimony attempts to minimize the number of independent mutation events, while maximum likelihood attempts to build the most likely tree given a specific nucleotide substitution matrix. These methods were developed using several assumptions, such as long timescales and independent evolution of each nucleotide, which do not hold for B-cell affinity maturation. Significant work remains to be done in order to validate and adapt these methods to B-cell Rep-seq analysis. Nevertheless, the existing approaches still form the basis for current Rep-seq studies. Many tools exist in evolutionary biology for phylogenetic tree construction [79–81]. The output of these tools is usually modified in B-cell trees to reflect common conventions in immunology, such as allowing observed sequences to appear as internal nodes in the tree and listing the specific nucleotide exchanges associated with each edge. Insights can be obtained by overlaying other sequence-specific information on the tree, including mutation frequencies , selection strengths , number of mRNAs observed , isotype [13, 14], or tissue location [9, 12, 77]. Lineage trees provide information on the temporal ordering of mutations, and this information can be used along with selection analysis methods to study temporal aspects of affinity maturation [73, 84, 85]. Quantitative analysis of lineage tree topologies has also been used to gain insights into the underlying population dynamics  and cell trafficking patterns between tissues [12, 13, 87]. In most current pipelines, grouping the sequences into clones and constructing lineage trees are separate steps. However, they are highly related and future methods may integrate these two steps.
The goal of this stage is to calculate quantitative features of the B-cell repertoire that can further be utilized for different aims such as: classification of data from different cohorts; isolating specific BCR populations for further study (for example, drug candidates); and identifying active and conserved residues of these specific BCR sequences. Effective visualizations are crucial to simplify these high-dimensional data, and Rep-seq analysis methods are associated with different types of plots that highlight specific features of these data (Fig. 3).
Estimating repertoire diversity, and linking changes in diversity with clinical status and outcomes is an active area of research [88, 89]. Multiple diversity measures have been studied intensively in the field of ecology, and many of the attempts that have been made so far to characterize diversity in immune repertoires have used these concepts and methods. In ecological terms, an individual animal is the analogue of a B cell while a species is the analogue of a clone. All diversity analyses begin from a table of clonal group sizes. Traditionally, the three main diversity measures are species richness, the Shannon entropy, and the Gini–Simpson index. Each reflects different aspects of diversity and has biases when applied to particular underlying populations in terms of size and abundance distribution. When two populations (repertoires in our case) are being compared, it can be the case that one diversity measure shows a certain trend while the other shows the opposite since they represent different aspects of the underlying abundance distributions . Moreover, these measures are dependent on the number of sampled B cells. Thus, sampling issues need to be addressed before diversity measures are compared. One strategy is to subsample the larger repertoire to the size of the smaller one and compare the two . Another approach is to interpolate the diversity measure for smaller sampling sizes and then to extrapolate from these subsamples the asymptotic values of each of the samples and compare them . It is important to note that when a repertoire is subsampled, the partitioning of sequences into clones needs to be redone on each subsampled population as clone definitions are influenced by sampling depth. In order to capture more information about the full clone size distribution, use of the Hill family of diversity indices has been advocated [91, 92]. The Hill indices are a generalization of the three measures mentioned above, and define diversity as a function of a continuous parameter q. q = 0 corresponds to clonal richness (number of clones), q = 1 is the exponential of the Shannon index, q = 2 is the reciprocal of the original Simpson index or one minus the Gini–Simpson index, and as q approaches infinity, the corresponding Hill index approaches the reciprocal of the largest clone frequency. Subsampling approaches can also be applied to the full Hill curve , resulting in a powerful set of repertoire features that can be used to characterize cells from different subsets, tissues, or disease states .
In the above discussion, clonal abundances were defined by the number of B cells in each clone. However, this is usually not measured directly. The mRNAs being sequenced are commonly pooled from many individual cells. Thus, observing multiple occurrences of the same sequence could be caused by PCR amplification of a single mRNA molecule, sampling multiple molecules from the same cell, or multiple cells expressing the same receptor. One strategy to estimate diversity is to group identical sequences together and analyze the set of unique sequences (these groups can be defined to include sequences that are similar as well to account for possible sequencing errors ). If each unique sequence corresponds to at least one independent cell, this provides a lower bound on diversity and other repertoire properties. Including UMIs in the experimental method helps to improve the diversity estimation by correcting for PCR amplification. However, some bias may be introduced because different cell subsets can express widely varying levels of BCR gene mRNAs, with antibody-secreting cells being especially high . Sequencing from multiple aliquots of the same sample can be used to estimate the frequency of cells expressing the same receptor . Emerging single-cell technologies will eventually provide a direct link between sequences and cells [70, 95], and may also provide insight into the contribution of transcription errors, estimated to be ~10−4 , to the observed mRNA diversity.
During adaptive immune responses, B cells undergo a process of SHM. Thus, even cells that are part of the same clone can express different receptors, which differs from T cells, in which all clonal members share the same receptor sequence. A crucial step in B-cell Rep-seq analysis is therefore to identify these somatic mutations. Having identified the germline state of the sequence using the methods described above, somatic mutations are called when the observed sequence and the inferred germline state differ. In carrying out this comparison, it is important to properly account for degenerate nucleotide symbols (that is, a “mismatch” with an N should not be counted as a mutation). It is common to calculate mutation frequencies for the V segment (up to the start of the junction) since the inferred germline state of the junction is less reliable. Mutations in the J segment (after the end of the junction) may also be included in the analysis. Somatic mutation frequencies are expressed in per bp units, so it is important to calculate the number of bases included in the analysis, and not use a per sequence average, in which the number of bases in each sequence may differ (for example, due to different primers, different V segment lengths, or the number of low-quality bases that were masked).
SHM does not target all positions in the BCR equally. There is a preference to mutate particular DNA motifs (hotspots) and not others (coldspots). WRCY is a classic hotspot motif, while SYC is a well-known coldspot motif . However, there is a wide range of mutabilities that depends on the local nucleotide context of each position [98, 99]. Mutability models can be estimated directly from Rep-seq data [99, 100], using tools such as Change-O . These models have a number of uses as differences in mutation patterns may be linked to the various enzymes involved in SHM . Mutability models also provide critical background models for the statistical analysis of selection, as described below. Methods to estimate mutability need to account for biases in the observed mutation patterns due to positive and/or negative selection pressures. Strategies include focusing on the set of non-functional sequences, using intronic sequences, or basing models on the set of silent (synonymous) mutations [99, 102, 103].
The frequency of somatic mutations is not uniform across the BCR. The V(D)J region of the BCR can be partitioned into framework regions (FWRs) and complementarity determining regions (CDRs) . FWRs typically have a lower observed mutation frequency, in part because they code for regions important to maintain structural integrity, and many mutations that alter the amino acid sequence are negatively selected . CDRs have higher observed mutation frequencies, in part because they contain more hotspot motifs and their structure is less constrained. Mutability models can be used to estimate the expected frequency of mutations in different regions of the V(D)J sequence. Deviations from the expectation provide useful biological information. It is common to look for an increased frequency of replacement (non-synonymous) mutations as evidence of antigen-driven positive selection, and a decreased frequency of replacement mutations as evidence of negative selection . Selection analysis has many applications, including the identification of potentially high-affinity sequences, understanding how different genetic manipulations impact affinity maturation, and investigating whether disease processes are antigen driven. Methods to detect selection based on the analysis of clonal lineage trees have also been proposed , as well as hybrid methods . Enrichment for mutations at specific positions can also be done by comparing the observed frequency with an empirical background distribution from a set of control sequences [72, 100, 109]. When comparing selection across biological conditions, it is important to remember that lower P values do not necessarily imply stronger selection, and methods such as BASELINe , which quantifies the strength of selection (rather than simply detecting its presence), should be employed. BASELINe defines selection strength as the log-odds ratio between the expected and observed frequencies of non-synonymous mutations, and estimates a full probability density for the strength using a Bayesian statistical framework. When discussing “selection”, it is important to distinguish between different types of selection that can occur during different phases of B-cell maturation. SHM and affinity maturation are processes that operate on mature B cells during adaptive immune responses. During development, immature B cells progress through several stages and are subject to central and peripheral checkpoints that select against autoreactive cells, leading to biased receptor properties (for example, changes in V segment usage, or the average length of the CDR3 region) . Probabilistic frameworks have been developed to model these properties, allowing them to be compared at various stages of development to determine which properties are influenced by this selection .
Stereotypic sequences and convergent evolution
B cells responding to common antigens may express BCRs with shared characteristics. These are referred to as stereotyped BCRs, and their identification is of significant interest . Stereotypic receptors can reflect germline characteristics (for example, the use of common V, D or J segments), or arise through convergent evolution, in which the accumulation of somatic mutations results in common amino acid sequences. These common patterns may serve as diagnostic markers . Stereotyped receptors have been observed in infections, autoimmunity and cancer .
Stereotyped sequences are commonly defined by having similar junctions. One way to observe them is to pool the data from several individuals together before carrying out the clonal grouping step. In this case, the distance function used for clonal grouping can be based on the amino acid sequence, rather than the nucleotide sequence (but note that these results no longer represent true clones). Sets of sequences that span multiple individuals can then be identified and extracted for more focused study. Although they exist, the percentage of such sequences is usually low. Significant overlap across individuals is most often the result of experimental problems, such as sample contamination or MID errors in multiplexed sequencing runs. Identification of shared amino acid motifs across the entire BCR sequence can be carried out using widely used motif finding tools . In these analyses, the choice of a control sequence set is critical and should account for germline segment usage and SHM. When looking for sequences with common features across individuals (or time points), it is important to consider statistical power. If the relevant sequences constitute a small percentage of the repertoire, then the ability to detect such sequences will depend on many experimental factors, including the number and type of cells sampled, the sequencing depth, and cohort heterogeneity. Statistical frameworks for power analysis in Rep-seq studies are lacking, and are an important area for future work.
Like the experimental technologies used to generate HTS data, the development of Rep-seq analysis methods is a fast-moving field. While computational methods have been developed to address important questions, many of the proposed tools have yet to be rigorously evaluated. Comparative studies, conducted on reference experimental and simulated data, are critical to have a quantitative basis for selecting the best methods to use in each step of the analysis. This will be facilitated by making the source code available for Rep-seq analysis tools, and not only providing web-based interfaces or services. Ideally, the source code should be posted in a public version control repository (such as bitbucket, github, Google source, or others) where bugs and comments can be reported. The community will also be aided by an active platform for informal discussions and evaluation of existing and new tools for Rep-seq analysis. The OMICtools directory  provides a promising step in this direction, and includes a dedicated Rep-seq section where a large list of current software tools can be found.
A challenge in developing computational pipelines using the kinds of methods described here is that each tool may require its own input format. Considerable effort is necessary to reformat data. For example, different V(D)J assignment tools can output the “junction sequence” but use different region definitions or numbering schemes. Ontologies can provide a formal framework for standardization of data elements, and a source of controlled vocabularies . A common data format for sequences and results can facilitate data sharing, as well as integration of methods and tools from multiple research groups. Many tools use tab-delimited files for data and analysis results, and XML-based schemes have also been proposed . Standardizing the terms used in column headers, or the XML tags, would greatly enhance interoperability. Some integrated frameworks are emerging, such as pRESTO/Change-O [30, 31], to provide standardized analysis methods in modular formats so that analysis pipelines can be rapidly developed and easily customized.
Many of the steps in Rep-seq analysis are computationally intensive, making them difficult to carry out on standard desktop computers. High-performance computing clusters, cloud-based services, as well as graphics processing unit (GPU)-enabled methods can help relieve this bottleneck. These approaches require programming expertise, or specifically designed tools. Some tools, such as IMGT/HighV-QUEST  or VDJServer , offer web-based front ends for some analysis steps, in which users can submit data to be analyzed on dedicated servers. For human studies, ethical issues with regards to patient confidentiality (for example, US Health Insurance Portability and Accountability Act (HIPAA) privacy restrictions) and governance over the use of sample-derived data need to be considered before uploading data onto public servers. These considerations are also important when the data are submitted to public repositories. Many current Rep-seq studies are made available through SRA or dbGAP , and only the latter has access control.
Novel computational methods continue to be developed to address each new improvement in sequencing technologies. Emerging techniques for high-throughput single-cell analysis (allowing for heavy and light chain pairing) will soon be adapted to sequence multiple genes along with the BCR, and eventually the full genome. This technological progress offers new opportunities for biological and clinical insights, and the computational methods discussed here will continue to evolve in this ongoing effort.
- 5′ RACE:
5′ rapid amplification of cDNA ends
B-cell immunoglobulin receptor
complementarity determining region
chromatin immunoprecipitation followed by sequencing
graphics processing unit
Health Insurance Portability and Accountability Act
insertion and deletion
unique molecular identifier
Boyd SD, Joshi SA. High-throughput DNA sequencing analysis of antibody repertoires. Microbiol Spectr. 2014;2. doi: 10.1128/microbiolspec.AID-0017-20.
Robins H. Immunosequencing: applications of immune repertoire deep sequencing. Curr Opin Immunol. 2013;25(5):646–52.
Arnaout R, Lee W, Cahill P, Honan T, Sparrow T, Weiand M, et al. High-resolution description of antibody heavy-chain repertoires in humans. PLoS One. 2011;6(8):22365.
Galson JD, Trück J, Fowler A, Münz M, Cerundolo V, Pollard AJ, et al. In-Depth Assessment of Within-Individual and Inter-Individual Variation in the B Cell Receptor Repertoire. Front. Immunol. 2015;6:1–13.
Boyd SD, Gaeta BA, Jackson KJ, Fire AZ, Marshall EL, Merker JD, et al. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol. 2010;184(12):6986–92.
Wu Y-C, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood. 2010;116(7):1070–8.
Cameron EM, Spencer S, Lazarini J, Harp CT, Ward ES, Burgoon M, et al. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J Neuroimmunol. 2009;213(1–2):123–30.
Zuckerman NS, Hazanov H, Barak M, Edelman H, Hess S, Shcolnik H, et al. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. J Autoimmun. 2010;35(4):325–35.
von Budingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest. 2012;122(12):4533–43.
Singh V, Stoop MP, Stingl C, Luitwieler RL, Dekker LJ, van Duijn MM, et al. Cerebrospinal-fluid-derived immunoglobulin G of different multiple sclerosis patients shares mutated sequences in complementarity determining regions. Mol Cell Proteomics. 2013;12(12):3924–34.
Lehmann-Horn K, Kronsbein HC, Weber MS. Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther Adv Neurol Disord. 2013;6(3):161–73.
Stern JN, Yaari G, Vander Heiden JA, Church G, Donahue WF, Hintzen RQ, et al. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med. 2014;6(248):248ra107.
Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med. 2014;6(248):248ra106.
Wu Y-CB, James LK, Vander Heiden JA, Uduman M, Durham SR, Kleinstein SH, et al. Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis. J Allergy Clin Immunol. 2014;134(3):604–12.
Patil SU, Ogunniyi AO, Calatroni A, Tadigotla VR, Ruiter B, Ma A, et al. Peanut oral immunotherapy transiently expands circulating Ara h 2–specific B cells with a homologous repertoire in unrelated subjects. J Allergy Clin Immunol. 2015;136(1):125–34.
Hoh RA, Joshi SA, Liu Y, Wang C, Roskin KM, Lee J-Y, et al. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol. 2015. doi: 10.1016/j.jaci.2015.05.029.
Lossos IS, Okada CY, Tibshirani R, Warnke R, Vose JM, Greiner TC, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000;95(5):1797–803.
Glanville J, Kuo TC, Budingen H-C, Guey L, Berka J, Sundar PD, et al. Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation. Proc Natl Acad Sci U S A. 2011;108(50):20066–71.
Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, et al. Non-invasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015;125(24):3679–87.
Dunn-Walters DK, Banerjee M, Mehr R. Effects of age on antibody affinity maturation. Biochem Soc Trans. 2003;31(2):447–8.
Dunn-Walters DK, Ademokun AA. B cell repertoire and ageing. Curr Opin Immunol. 2010;22(4):514–20.
Ademokun A, Wu Y-C, Martin V, Mitra R, Sack U, Baxendale H, et al. Vaccination-induced changes in human B-cell repertoire and pneumococcal IgM and IgA antibody at different ages. Aging Cell. 2011;10(6):922–30.
Martin V, Wu Y-CB, Kipling D, Dunn-Walters D. Ageing of the B-cell repertoire. Phil Trans R Soc B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.0237.
Reddy ST, Ge X, Miklos AE, Hughes RA, Kang SH, Hoi KH, et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells. Nat Biotechnol. 2010;28(9):965–9.
Cheung WC, Beausoleil SA, Zhang X, Sato S, Schieferl SM, Wieler JS, et al. A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat Biotechnol. 2012;30(5):447–52.
Zhu J, Wu X, Zhang B, McKee K, O’Dell S, Soto C, et al. De novo identification of VRC01 class HIV-1 neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc Natl Acad Sci U S A. 2013;110(43):E4088–97.
Georgiou G, Ippolito GC, Beausang J, Busse CE, Wardemann H, Quake SR. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol. 2014;32(2):158–68.
Ganusov VV, De Boer RJ. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 2007;28(12):514–8.
Benichou J, Ben-Hamo R, Louzoun Y, Efroni S. Rep-seq: uncovering the immunological repertoire through next-generation sequencing. Immunology. 2012;135(3):183–91.
Vander Heiden JA, Yaari G, Uduman M, Stern JNH, O’Connor KC, Hafler DA, et al. pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics. 2014;30(13):1930–2.
Gupta NT, Vander Heiden J, Uduman M, Gadala-Maria D, Yaari G, Kleinstein SH. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics. 2015;31(20):3356–8.
Cock PJ, Fields CJ, Goto N, Heuer ML, Rice PM. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2010;38(6):1767–71.
Kuchenbecker L, Nienen M, Hecht J, Neumann AU, Babel N, Reinert K, et al. IMSEQ—a fast and error aware approach to immunogenetic sequence analysis. Bioinformatics. 2015;31(18):2963–71.
Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8(3):186–94.
Rodrigue S, Materna AC, Timberlake SC, Blackburn MC, Malmstrom RR, Alm EJ, et al. Unlocking short read sequencing for metagenomics. PLoS One. 2010;5(7):11840.
Aoki-Ota M, Torkamani A, Ota T, Schork N, Nemazee D. Skewed primary Igκ repertoire and V–J joining in C57BL/6 mice: implications for recombination accessibility and receptor editing. J Immunol. 2012;188(5):2305–15.
Choi NM, Loguercio S, Verma-Gaur J, Degner SC, Torkamani A, Su AI, et al. Deep sequencing of the murine IgH repertoire reveals complex regulation of nonrandom V gene rearrangement frequencies. J Immunol. 2013;191(5):2393–402.
Masella AP, Bartram AK, Truszkowski JM, Brown DG, Neufeld JD. PANDAseq: paired-end assembler for Illumina sequences. BMC Bioinformatics. 2012;13:31.
Zhang J, Kobert K, Flouri T, Stamatakis A. Pear: a fast and accurate Illumina paired-end read merger. Bioinformatics. 2014;30(5):614–20.
Edgar RC. Search and clustering orders of magnitude faster than Blast. Bioinformatics. 2010;26(19):2460–1.
Vollmers C, Sit RV, Weinstein JA, Dekker CL, Quake SR. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc Natl Acad Sci U S A. 2013;110(33):13463–8.
He L, Sok D, Azadnia P, Hsueh J, Landais E, Simek M, et al. Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding. Sci Rep. 2014;4:6778.
Liang RH, Mo T, Dong W, Lee GQ, Swenson LC, McCloskey RM, et al. Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing. Nucleic Acids Res. 2014;42(12):e98.
Shugay M, Britanova OV, Merzlyak EM, Turchaninova MA, Mamedov IZ, Tuganbaev TR, et al. Towards error-free profiling of immune repertoires. Nat Methods. 2014;11(6):653–5.
Larimore K, McCormick MW, Robins HS, Greenberg PD. Shaping of human germline IgH repertoires revealed by deep sequencing. J Immunol. 2012;189(6):3221–30.
Alamyar E, Giudicelli V, Li S, Duroux P, Lefranc M-P. IMGT/HighV-QUEST: the IMGT web portal for immunoglobulin (Ig) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing. Immune Res. 2012;8:1–15.
Ye J, Ma N, Madden TL, Ostell JM. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013;41:W34–40.
Gaeta BA, Malming HR, Jackson KJL, Bain ME, Wilson P, Collins AM. iHMMune-align: hidden Markov model-based alignment and identification of germline genes in rearranged immunoglobulin gene sequences. Bioinformatics. 2007;23(13):1580–7.
Munshaw S, Kepler TB. SoDA2: a hidden Markov model approach for identification of immunoglobulin rearrangements. Bioinformatics. 2010;26(7):867–72.
Ralph DK, Matsen I, Frederick A. Consistency of VDJ rearrangement and substitution parameters enables accurate B cell receptor sequence annotation. 2015. http://arxiv.org/abs/1503.04224.
Frost SD, Murrell B, Hossain AMM, Silverman GJ, Pond SLK. Assigning and visualizing germline genes in antibody repertoires. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.0240.
Lakhani KR, Boudreau KJ, Loh P-R, Backstrom L, Baldwin C, Lonstein E, et al. Prize-based contests can provide solutions to computational biology problems. Nat Biotechnol. 2013;31(2):108–11.
Wang Y, Jackson KJ, Sewell WA, Collins AM. Many human immunoglobulin heavy-chain IGHV gene polymorphisms have been reported in error. Immunol Cell Biol. 2007;86(2):111–5.
Wang Y, Jackson KJ, Gäeta B, Pomat W, Siba P, Sewell WA, et al. Genomic screening by 454 pyrosequencing identifies a new human IGHV gene and sixteen other new IGHV allelic variants. Immunogenetics. 2011;63(5):259–65.
Watson CT, Breden F. The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease. Genes Immun. 2012;13(5):363–73.
Gadala-Maria D, Yaari G, Uduman M, Kleinstein SH. Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles. Proc Natl Acad Sci U S A. 2015;112(8):862–70.
Guo Y, Bao Y, Wang H, Hu X, Zhao Z, Li N, et al. A preliminary analysis of the immunoglobulin genes in the African elephant (loxodonta Africana). PLoS One. 2011;6(2):e16889.
Olivieri D, Gambon-Deza F. V genes in primates from whole genome sequencing data. Immunogenetics. 2015;67(4):211–28.
Qin T, Zhao H, Zhu H, Wang D, Du W, Hao H. Immunoglobulin genomics in the prairie vole (Microtus ochrogaster). Immunol Lett. 2015;166(2):79–86.
Walther S, Rusitzka TV, Diesterbeck US, Czerny C-P. Equine immunoglobulins and organization of immunoglobulin genes. Dev Comp Immunol. 2015;53(2):303–19.
Kidd MJ, Chen Z, Wang Y, Jackson KJ, Zhang L, Boyd SD, et al. The inference of phased haplotypes for the immunoglobulin H chain V region gene loci by analysis of VDJ gene rearrangements. J Immunol. 2012;188(3):1333–40.
Kepler TB, Liao H-X, Alam SM, Bhaskarabhatla R, Zhang R, Yandava C, et al. Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies. Cell Host Microbe. 2014;16(3):304–13.
Murphy K. Janeway’s immunobiology. 8th ed. New York: Garland Science; 2011.
Barak M, Zuckerman NS, Edelman H, Unger R, Mehr R. IgTreeQc: creating immunoglobulin variable region gene lineage trees. J Immunol Methods. 2008;338(1–2):67–74.
Bolotin DA, Poslavsky S, Mitrophanov I, Shugay M, Mamedov IZ, Putintseva EV, et al. Mixcr: software for comprehensive adaptive immunity profiling. Nat Methods. 2015;12(5):380–1.
Chen Z, Collins AM, Wang Y, Gäeta BA. Clustering-based identification of clonally-related immunoglobulin gene sequence sets. Immunome Res. 2010;6 Suppl 1:S4.
Hershberg U, Prak ETL. The analysis of clonal expansions in normal and autoimmune B cell repertoires. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.0239.
DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol. 2013;31(2):166–9.
DeKosky BJ, Kojima T, Rodin A, Charab W, Ippolito GC, Ellington AD, et al. In-depth determination and analysis of the human paired heavy-and light-chain antibody repertoire. Nat Med. 2015;21(1):86–91.
Parameswaran P, Liu Y, Roskin K, Jackson K, Dixit V, Lee J-Y, et al. Convergent antibody signatures in human dengue. Cell Host Microbe. 2013;13(6):691–700.
Jackson KJ, Liu Y, Roskin KM, Glanville J, Hoh RA, Seo K, et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe. 2014;16(1):105–14.
Liberman G, Benichou J, Tsaban L, Glanville J, Louzoun Y. Multi step selection in Ig H chains is initially focused on CDR3 and then on other CDR regions. Front Immunol. 2013;4:424.
Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, et al. Focused evolution of hiv-1 neutralizing antibodies revealed by structures and deep sequencing. Science. 2011;333(6049):1593–602.
Kepler TB. Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors. F1000 Res. 2013;2:103.
Giraud M, Salson M, Duez M, Villenet C, Quief S, Caillault A, et al. Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing. BMC Genomics. 2014;15(1):409.
Snir O, Mesin L, Gidoni M, Lundin KE, Yaari G, Sollid LM. Analysis of celiac disease autoreactive gut plasma cells and their corresponding memory compartment in peripheral blood using high-throughput sequencing. J Immunol. 2015;194(12):5703–12.
Nei M, Kumar S. Molecular evolution and phylogenetics. New York: Oxford University Press; 2000.
Felsenstein J. Phylip(phylogeny inference package) version 3.6 a3. Seattle: Department of Genome Sciences, University of Washington; 2002.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731–9.
Drummond AJ, Rambaut A. Beast: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7(1):214.
Sok D, Laserson U, Laserson J, Liu Y, Vigneault F, Julien J-P, et al. The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. PLoS Pathog. 2013;9(11):e1003754.
Laserson U, Vigneault F, Yaari G, Gadala-Maria D, Uduman M, Heiden JAV, et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A. 2014;111(13):4928–33.
Kepler TB, Munshaw S, Wiehe K, Zhang R, Yu J-S, Woods CW, et al. Reconstructing a B-cell clonal lineage. II. Mutation, selection, and affinity maturation. Front Immunol. 2014;5:170.
Yaari G, Benichou JI, Vander Heiden JA, Kleinstein SH, Louzoun Y. The mutation patterns in B-cell immunoglobulin receptors reflect the influence of selection acting at multiple time-scales. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.0242.
Dunn-Walters DK, Belelovsky A, Edelman H, Banerjee M, Mehr R. The dynamics of germinal centre selection as measured by graph-theoretical analysis of mutational lineage trees. Clin Dev Immunol. 2002;9(4):233–43.
Tabibian-Keissar H, Zuckerman NS, Barak M, Dunn-Walters DK, Steiman-Shimony A, Chowers Y, et al. B-cell clonal diversification and gut-lymph node trafficking in ulcerative colitis revealed using lineage tree analysis. Eur J Immunol. 2008;38(9):2600–9.
Gibson KL, Wu Y-C, Barnett Y, Duggan O, Vaughan R, Kondeatis E, et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell. 2009;8(1):18–25.
Greiff V, Bhat P, Cook SC, Menzel U, Kang W, Reddy ST. A bioinformatic framework for immune repertoire diversity profiling enables detection of immunological status. Genome Med. 2015;7(1):49.
Chao A, Gotelli NJ, Hsieh T, Sander EL, Ma K, Colwell RK, et al. Rarefaction and extrapolation with Hill numbers: a framework for sampling and estimation in species diversity studies. Ecol Monogr. 2014;84(1):45–67.
Hill MO. Diversity and evenness: a unifying notation and its consequences. Ecology. 1973;54(2):427.
Tuomisto H. A consistent terminology for quantifying species diversity? Yes, it does exist. Oecologia. 2010;164(4):853–60.
Shi W, Liao Y, Willis SN, Taubenheim N, Inouye M, Tarlinton DM, et al. Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells. Nat Immunol. 2015;16(6):663–73.
Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med. 2009;1(12):12ra23.
Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161(5):1202–14.
Milo R, Jorgensen P, Moran U, Weber G, Springer M. Bionumbers—the database of key numbers in molecular and cell biology. Nucleic Acids Res. 2010;38 Suppl 1:750–3.
Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, et al. The biochemistry of somatic hypermutation. Annu Rev Immunol. 2008;26:481–511.
Shapiro GS, Aviszus K, Ikle D, Wysocki LJ. Predicting regional mutability in antibody V genes based solely on di- and trinucleotide sequence composition. J Immunol. 1999;163(1):259–68.
Yaari G, Vander Heiden J, Uduman M, Gadala-Maria D, Gupta N, Stern JNH, et al. Models of somatic hypermutation targeting and substitution based on synonymous mutations from high-throughput Immunoglobulin sequencing data. Front Immunol. 2013;4:358.
Elhanati Y, Sethna Z, Marcou Q, Callan CG Jr, Mora T, Walczak AM. Inferring processes underlying B-cell repertoire diversity. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.024320140243.
Odegard VH, Schatz DG. Targeting of somatic hypermutation. Nat Rev Immunol. 2006;6(8):573–83.
MacCarthy T, Kalis SL, Roa S, Pham P, Goodman MF, Scharff MD, et al. V-region mutation in vitro, in vivo, and in silico reveal the importance of the enzymatic properties of aid and the sequence environment. Proc Natl Acad Sci U S A. 2009;106(21):8629–34.
Duke JL, Liu M, Yaari G, Khalil AM, Tomayko MM, Shlomchik MJ, et al. Multiple transcription factor binding sites predict aid targeting in non-Ig genes. J Immunol. 2013;190(8):3878–88.
Lefranc M-P, Pommié C, Ruiz M, Giudicelli V, Foulquier E, Truong L, et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol. 2003;27(1):55–77.
Shlomchik M, Litwin S, Weigert M. The influence of somatic mutation on clonal expansion. In: Progress in immunology. Berlin: Springer; 1989. p. 415–23.
Hershberg U, Uduman M, Shlomchik MJ, Kleinstein SH. Improved methods for detecting selection by mutation analysis of Ig V region sequences. Int Immunol. 2008;20(5):683–94.
Steiman-Shimony A, Edelman H, Hutzler A, Barak M, Zuckerman NS, Shahaf G, et al. Lineage tree analysis of immunoglobulin variable-region gene mutations in autoimmune diseases: chronic activation, normal selection. Cell Immunol. 2006;244(2):130–6.
Uduman M, Shlomchik MJ, Vigneault F, Church GM, Kleinstein SH. Integrating B cell lineage information into statistical tests for detecting selection in Ig sequences. J Immunol. 2014;192(3):867–74.
Mccoy CO, Bedford T, Minin VN, Robins H, Matsen FA IV. Quantifying evolutionary constraints on B-cell affinity maturation. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.0244.
Yaari G, Uduman M, Kleinstein SH. Quantifying selection in high-throughput immunoglobulin sequencing data sets. Nucleic Acids Res. 2012;40(17):e134.
Dunand CJH, Wilson PC. Restricted, canonical, stereotyped and convergent immunoglobulin responses. Philos Trans R Soc Lond B Biol Sci. 2015;370(1676). doi: 10.1098/rstb.2014.0238.
Rounds WH, Salinas EA, Wilks TB, Levin MK, Ligocki AJ, Ionete C, et al. MSPrecise: molecular diagnostic test for multiple sclerosis using next generation sequencing. Gene. 2015;572(2):191–7.
Bailey TL, Johnson J, Grant CE, Noble WS. The MEME suite. Nucleic Acids Res. 2015;43(W1):W39–49.
Henry VJ, Bandrowski AE, Pepin A-S, Gonzalez BJ, Desfeux A. OMICtools: an informative directory for multi-omic data analysis. Database. 2014;2014:069.
Giudicelli V, Lefranc M-P. Ontology for immunogenetics: the IMGT-ontology. Bioinformatics. 1999;15(12):1047–54.
Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R, et al. The NCBI dbGaP database of genotypes and phenotypes. Nat Genet. 2007;39(10):1181–6.
McKean D, Huppi K, Bell M, Staudt L, Gerhard W, Weigert M. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A. 1984;81(10):3180–4.
Kleinstein SH, Louzoun Y, Shlomchik MJ. Estimating hypermutation rates from clonal tree data. J Immunol. 2003;171(9):4639–49.
Shlomchik MJ, Weisel F. Germinal centers. Immunolog Rev. 2012;247(1):5–10.
This work was supported by a United States–Israel Binational Science Foundation grant (2013395), and the National Institutes of Health (RO1AI104739). The authors wish to thank Jason Vander Heiden, Rebecca Katz, Mohamed Uduman, Moriah Gidoni, and Uri Hershberg for helpful discussions and commenting on the manuscript.
The authors declare that they have no competing interests.
About this article
Cite this article
Yaari, G., Kleinstein, S.H. Practical guidelines for B-cell receptor repertoire sequencing analysis. Genome Med 7, 121 (2015) doi:10.1186/s13073-015-0243-2
- Somatic Mutation
- Affinity Maturation
- Versus Segment
- Clonal Grouping
- Rearrangement Process